Navigation Links
New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia

e - on PANSS total score after two weeks of treatment. Early responders were compared to early non-responders (patients that did not show at least a minimal level of early improvement) on symptom remission, physical and mental health functioning, perceptions of medication influence, and total healthcare costs at eight weeks. Statistically significant findings included:

     - Early response or non-response at two weeks predicted subsequent

       response or non-response at eight weeks with a high overall level of

       accuracy (73 percent).

     - Almost all (88.7 percent) of non-responders at eight weeks were

       correctly identified at two weeks (high specificity).

     - Early non-responders were less likely to achieve symptom remission

       after eight weeks of treatment with the same antipsychotic (only 27.5

       percent of early non-responders achieved remission vs. 46.9 percent of

       responders, p<0.001).

     - Early non-responders improved less on physical and mental functioning

       (p<0.05), perceived adherence with medication as less beneficial

       (p<0.05), and incurred nearly twice as many total healthcare costs

       ($4,336 vs. $2,102, p<0.01).

These data need to be evaluated in the context of their limitations. These were post-hoc analyses limited to patients who completed eight weeks of treatment on the initially randomized medication. There is a need for additional research that measures a priori the predictive accuracy of early non-response as a reliable marker of subsequent non-response. There is also a need for additional studies that assess a priori the clinical, functional, and healthcare costs of early non-responders to antipsychotic medication regimens, and whether changes in the initial regimens result in subsequent improvements in treatment outcomes.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-cl
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
2. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
3. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
4. Promising Data on Cognitive Effects of Safinamide in Early Parkinsons Disease
5. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
6. Clinical Trial Excellence: Shaping Markets Through Early Communication of Clinical Trial Data
7. Separate Sets of Research Show Treatment Improved Quality of Life in as Early as Three Weeks; Patient Adherence to Medication is Multifactorial
8. Early Results of the CellCept Spare the Nephron Study Examine Kidney Function
9. Studies Presented at Neurology Conference Highlight Early Efficacy, Long-Term Tolerability, and High Patient Satisfaction with Betaseron
10. Immediate Treatment of Early MS Patients with Betaferon Significantly Delayed Permanent Disability
11. First of Its Kind Data Show: Immediate Treatment of Early MS Patients with Betaseron Significantly Delayed Permanent Disability

Post Your Comments:
(Date:11/9/2009)...Texas, Nov. 9 Celling Technologies...ating with Tissue Genesis, Inc. to research potent...stem cells. SpineSmith acquired the global rights... derived stem cell technology in November of 2007....ive agreement allows Celling Technologies to furth...
(Date:11/9/2009)...FALLS, Va., Nov. 9 TessArae® ...sed applications, announces the launch of new inte...e mutations that underlie human hereditary disease...roarray-based resequencing with novel nucleotide s...re enables screening for all targeted mutations in...
(Date:11/9/2009)...E, Calif., Nov. 9 Asthmatx, Inc. p...igating the effectiveness and safety of bronchial ...and how this new procedure will impact allergy pra...Annual Meeting of the American College of Allergy,...a. ,, The poster, titled "Where Could Bronchial...
Breaking Medicine Technology:Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 2Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 3TessArae Delivers Lower Cost Option to Genetic Testing Market 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 3synthesis Whats the Real Objective Outcomes 21 56946 1Curbing Obesity Epidemic Key to Health Care Reform 3A Experts 56942 1Curbing Obesity Epidemic Key to Health Care Reform 3A Experts 56942 2Curbing Obesity Epidemic Key to Health Care Reform 3A Experts 56942 3The change in Arctic nature foreshadows the global environment of the future 9891 1The change in Arctic nature foreshadows the global environment of the future 9891 2
...ygiene measures for patients,...S, Sept. 30 Resurgent,Health and Medical, a leade...gy, announced today that Children,s Hospitals and ...andwashing systems for its locations,in Minneapoli...located in,various hallways for all medical staff,...
...d heart pumps helped keep children alive,who were ... approved for general use in the United States., ...c patients with severe heart failure were successf...iaturized heart assist pumps while,awaiting a hear...ascular,Surgery Supplement of Circulation: Journal...
Other Medicine Technology:Resurgent Health and Medical Announces That Children's Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems 2American Heart Association Journal Report: Miniaturized Heart Pumps May Be Effective for Children Awaiting Transplant 2
(Date:11/9/2009)...ORK, Nov. 9 /PRNewswire/ -- Phoenix House , t...use treatment and prevention program, announced to...nally and internationally recognized leader in sub...ical Officer, effective January 1, 2010. ,, "...nce abuse treatment research and her work has resu...
(Date:11/9/2009)...NGTON, Nov. 9 Speaker ...sing provisions in the Affordable Health Care for ...ss to Medicaid and reduce Medicare Part D costs fo...e House on Saturday by a vote of 220 to 215: ,...alth and quality of life for thousands of American...
(Date:11/9/2009)...STER, Minn., Nov. 9 New...ry for vaginal prolapse dramatically reduces p...ings are being presented this week at the North Ce...on in Scottsdale, Ariz. ,, (Logo: http://www..., VIDEO ALERT : Additional audio and video reso...
(Date:11/9/2009)...IDGE, Mass., Nov. 9 Abt Associat...ties in delivering emergency management consulting...contracts to support the work of the Federal Emerg... Operations, the National Commission on Children a...Transit Authority (WMATA). The value of the combi...
(Date:11/9/2009)...FIELD, Maine, Nov. 9 At a time whe...ne are increasingly concerned about finding afford... Medicare option for 2010. ,, The Today,s Optio...icare Advantage plan provides a cost-effective and... a Medicare Supplement plan. People with Medicare...
Breaking Medicine News(10 mins):Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 2Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 3Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2
...ificial heart was approved by the U.S. Food and Dr...al heart has been approved for patients with sever...plant. Under the FDA's Humanitarian Use Device... per year. The usage of this artificial heart is r...
... about 300 million poultry next month against bird...ls in the midst of large-scale criticism over the ...nced that the government plans of mass vaccination...rged Jakarta to give precedence for controlling th...
...em that could help in determining the condition of...do Silvio Nu?o Almirantearena has developed a new ...rt attack, brain stroke or high blood pressure, by...agnosis of the condition of the arterial system in...
...of Clinical Investigation and the September issue ... Monash University have reported that a new drug h...nd heart attacks by improving the blood flow in di... of the arteries. The finding is a significa...
... Zero after 9/11 are struggling with serious healt...to advocates.// "When we were needed on 9/11, no o...re anymore," said Lucelly Gil, who was present in ... necessary protection. "All of us who worked in th...
...t it has asked EU health authorities to re-examine...reatment Tarceva.// The European Committee for Me... rejected the Tarceva application. "People wi...ady been approved for this indication in the US," ...
Other Medicine News:Health News:First Implantable artificial heart gets FDA’s approva 2Health News:Indonesia To Conduct Mass Vaccination Of Poultry 2Health News:A New System Developed For Studying The Condition Of The Human Arterial System 2Health News:A New Drug That Could Revolutionize Management Of Heart Disease 2
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
Medicine Products: